Medicamen Biotech consolidated net profit rises 82.88% in the September 2025 quarter
Sales rise 5.43% to Rs 47.17 crore
Net profit of Medicamen Biotech rose 82.88% to Rs 2.67 crore in the quarter ended September 2025 as against Rs 1.46 crore during the previous quarter ended September 2024. Sales rose 5.43% to Rs 47.17 crore in the quarter ended September 2025 as against Rs 44.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales47.1744.74 5 OPM %10.9411.87 -PBDT4.544.56 0 PBT2.681.96 37 NP2.671.46 83Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2025 | 4:17 PM IST